Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

PHASE2,PHASE3

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Premature end of recruitment due to lack of eligible patients. Within two years of recruitment only nine patients could be randomized out of 130 required patients as per trial protocol.

Conditions

Inflammatory Cardiomyopathy

Interventions

DRUG: Mycophenolate Mofetil
DRUG: Prednisolone
DRUG: Mycophenolate Mofetil Placebo
DRUG: Prednisolone Placebo

Sponsor

LMU Klinikum

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]